WASHINGTON - eTradeWire -- NJ MED (New Jersey Minority Educational Development) announces its annual National High School Graduation Campaign for the Class of 2024.  This is the sixth annual pledge campaign that asks incoming high school freshmen in America, to live drug free, become computer literate, not become a teen parent, graduate on time, and promise to enroll in higher education after graduation.

Due to the COVID 19 pandemic, last year's graduation class's graduation ceremonies were held online for most of the country.  This year's incoming freshman class enrollment in the campaign will be challenging, Due to the fact, many school's doors have been closed due to the pandemic.

Mr. Albert Mitchell II, CEO/Founder of NJ MED, said "Nothing is the same, but our goals. We need now more than ever to focus on our future, Will things return to the way they were, the answer is highly likely yes. Has this pandemic affected the way life is, yes, and will it ever be the same, no? Not the same. But better."

More on eTradeWire News

• Wedding Photographs Finalists in Street Photography Competition
• Beta-Glucan Assay Kit (Fluorometric)
• How Physical Therapy Can Help With Back Pain
• Teri Isner Awarded Prestigious "Premier Luxury Marketing Consultant" Certification
• China Refuses to Accept Service of Berman Law Group's Coronavirus Class Action Complaint

Mr. Mitchell II, added, " Since the pandemic, the world has become more digital and tech savvy, Therefore,  creating a need for a more knowledge workplace and space for all of us.  This proves our mission is on track for preparing America for the challenge. We hope more schools, communities, and parents understand this and make sure their students join this year's pledge. In this time of uncertainties, we need a population ready to move forward."

This year schools and students can get their pledge form at NJ MED's website at  https://usstudentpledge.org/

For more information about the National High School Graduation Campaign, please contact Mr. Shomar Moore at NJ MED.